ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

Ultmann Appeals For Better Funding, Cancer Act Renewal

June 28, 1985

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

Kurzrock and Ferrara Join UCSD Moores Cancer Center

January 25, 2013

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986

Avastin Loses Indication for Breast Cancer

November 18, 2011

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990